These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 3559272)

  • 1. Partial characterization of phospholipase C activity in normal, psoriatic uninvolved, and lesional epidermis.
    Bartel RL; Marcelo CL; Voorhees JJ
    J Invest Dermatol; 1987 Apr; 88(4):447-51. PubMed ID: 3559272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased phospholipase C-catalyzed hydrolysis of phosphatidylinositol-4,5-bisphosphate and 1,2-sn-diacylglycerol content in psoriatic involved compared to uninvolved and normal epidermis.
    Fisher GJ; Talwar HS; Baldassare JJ; Henderson PA; Voorhees JJ
    J Invest Dermatol; 1990 Oct; 95(4):428-35. PubMed ID: 2170539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated expression of human nonpancreatic phospholipase A2 in psoriatic tissue.
    Andersen S; Sjursen W; Laegreid A; Volden G; Johansen B
    Inflammation; 1994 Feb; 18(1):1-12. PubMed ID: 8206642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased phosphatidylinositol kinase activity in psoriatic epidermis.
    Pike MC; Lee CS; Elder JT; Voorhees JJ; Fisher GJ
    J Invest Dermatol; 1989 Jun; 92(6):791-7. PubMed ID: 2542414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of phospholipase A2 activity in extracts of lesion-free psoriatic epidermis by alkaline phosphatase and a protein phosphatase inhibitor.
    Cartwright PH; Ilchyshyn A; Ilderton E; Yardley HJ
    Br J Dermatol; 1988 Mar; 118(3):333-8. PubMed ID: 2833303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization and activity of phospholipase A2 in normal human epidermis and in lesion-free epidermis of patients with psoriasis or eczema.
    Forster S; Ilderton E; Norris JF; Summerly R; Yardley HJ
    Br J Dermatol; 1985 Feb; 112(2):135-47. PubMed ID: 3970838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased lysophosphatidylcholine content in lesional psoriatic skin.
    Ryborg AK; Grøn B; Kragballe K
    Br J Dermatol; 1995 Sep; 133(3):398-402. PubMed ID: 8546994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidermal phospholipase A2 activity is raised in the uninvolved skin of psoriasis.
    Forster S; Ilderton E; Summerly R; Yardley HJ
    Br J Dermatol; 1983 Jul; 109 Suppl 25():30-5. PubMed ID: 6860582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Membrane-bound phospholipase C activity in normal and psoriatic epidermis.
    Bergers M; van de Kerkhof PC; Happle R; Mier PD
    Acta Derm Venereol; 1990; 70(1):57-9. PubMed ID: 1967875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet activating factor (PAF) and lyso-PAF in psoriasis.
    Judge MR; Barr RM; Mallet AI; Courtney F; Kobza Black A; Greaves MW
    Arch Dermatol Res; 1994; 286(7):376-9. PubMed ID: 7818279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biosynthesis of lipoxygenase products by enzyme preparations from normal and psoriatic skin.
    Ziboh VA; Casebolt TL; Marcelo CL; Voorhees JJ
    J Invest Dermatol; 1984 Dec; 83(6):426-30. PubMed ID: 6094672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of ribosomal protein S6 kinase in psoriatic lesions and cultured human keratinocytes by epidermal growth factor receptor ligands.
    Choi JH; O'Connor TP; Kang S; Voorhees JJ; Fisher GJ
    J Invest Dermatol; 1997 Jan; 108(1):98-102. PubMed ID: 8980296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased protein kinase C activity in psoriatic versus normal epidermis.
    Horn F; Marks F; Fisher GJ; Marcelo CL; Voorhees JJ
    J Invest Dermatol; 1987 Feb; 88(2):220-2. PubMed ID: 3805758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated phosphorylase kinase activity in psoriatic epidermis: correlation with increased phosphorylation and psoriatic activity.
    Heng MC; Song MK; Heng MK
    Br J Dermatol; 1994 Mar; 130(3):298-306. PubMed ID: 8148269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biologically active calmodulin levels are elevated in both involved and uninvolved epidermis in psoriasis.
    Tucker WF; MacNeil S; Bleehen SS; Tomlinson S
    J Invest Dermatol; 1984 Mar; 82(3):298-9. PubMed ID: 6321604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclophilin content of normal and psoriatic epidermis.
    Griffiths CE; Fisher GJ; Harding MW; Elder JT; Voorhees JJ
    J Invest Dermatol; 1990 Apr; 94(4):436-40. PubMed ID: 2179418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Possible defects in triacylglycerol and phosphatidylcholine metabolism in psoriatic epidermis.
    Summerly R; Ilderton E; Gray GM
    Br J Dermatol; 1978 Sep; 99(3):279-88. PubMed ID: 708594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of plasminogen activator enzymes in psoriatic epidermis.
    Spiers EM; Lazarus GS; Lyons-Giordano B
    J Invest Dermatol; 1994 Mar; 102(3):333-8. PubMed ID: 8120416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphatidylinositol hydrolysis in isolated guinea-pig islets of Langerhans.
    Schrey MP; Montague W
    Biochem J; 1983 Nov; 216(2):433-41. PubMed ID: 6362663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased activity and stimulability of psoriatic epidermal soluble guanylate cyclase by arachidonic acid and 12-hydroxy-5,8,10,14-eicosatetraenoic acid.
    Cantieri JS; Graff G; Goldberg ND
    Adv Cyclic Nucleotide Res; 1980; 12():139-46. PubMed ID: 6105812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.